Methylenedioxybenzylamphetamine

From Wikipedia, the free encyclopedia
  (Redirected from MDBZ)
Jump to: navigation, search
Methylenedioxybenzylamphetamine
MDBZ.png
Names
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-benzylpropan-2-amine
Identifiers
65033-29-6 YesY
3D model (Jmol) Interactive image
UNII QR8242661A N
Properties
C17H19NO2
Molar mass 269.343 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

MDBZ, or 3,4-methylenedioxy-N-benzylamphetamine, is a lesser-known psychedelic drug. It is the N-benzyl derivative of MDA. MDBZ was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 150 mg, and the duration unknown. MDBZ produces few to no effects. Very few data exist about the pharmacological properties, metabolism, and toxicity of MDBZ.

In an episode of the British spoof documentary TV show Brass Eye, David Amess MP was fooled into recording a warning against a fictitious new drug called "cake". When asked a parliamentary question about it, the Home Office incorrectly assumed Amess was referring to 3,4-methylenedioxy-N-benzylamphetamine.[1]

See also[edit]

References[edit]

External links[edit]